Pham Quang X 4

What Happened
Pham Quang, a 10% owner (trustee of The PVBQ Living Trust), sold a total of 652 Cadrenal Therapeutics (CVKD) shares in two open‑market transactions for roughly $3,075. On 2026-05-29 he sold 303 shares at a weighted average price of $5.01 (≈ $1,518). On 2026-06-02 he sold 349 shares at a weighted average price of $4.46 (≈ $1,557). These were sales (not purchases) and were executed under a prearranged Rule 10b5‑1 trading plan.

Key Details

• Transaction dates: 2026-05-29 (303 shares, weighted avg $5.00–$5.02; reported $5.01) and 2026-06-02 (349 shares, weighted avg $4.40–$4.62; reported $4.46).
• Total shares sold: 652; approximate proceeds: $3,075.
• Reporting/filing: Form 4 filed 2026-06-02 (appears timely for the reported trades).
• Ownership after transaction: Not disclosed in the provided filing excerpt.
• Notable footnotes: Sales were made pursuant to a Rule 10b5‑1 plan adopted Sept 25, 2025; weighted‑average prices reported with ranges and the reporting person will supply per‑price breakdowns on request; Pham is trustee with sole voting/dispositive power for shares held in The PVBQ Living Trust (beneficiary: his child).

Context
These are routine sales under a prearranged 10b5‑1 plan by a significant (10%) owner via a trust. The total dollar amount is small relative to typical insider trades; sales do not necessarily signal management view of the company.